TwitterLinkedin

Contact Us

  • Biopharma Excellence
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistics and Data Sciences
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistics and Data Sciences
          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistics and Data Sciences
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR (Individual Safety Case Report) Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Post-Brexit Regulatory Support
            • Statistics and Data Sciences
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Career Opportunities
  • Training
Home > News & Events > Ireland > Behavioural Culture in the Workplace

Behavioural Culture in the Workplace

The Importance of Self-Awareness on Behavioural Culture in the Workplace.

Practicing self-awareness does not need to be a time consuming, planned or structured process. It merely involves taking a few quiet minutes for yourself at periodic intervals and asking yourself a few key self-reflecting questions. Why not try it right now by reflecting on the following:

  • How would I describe myself as an individual; what makes me tick, how do I approach, behave and respond to my peers?
  • What does “normal” look like to me? Do I know what “normal” looks like to my peers? Is it the same or different?
  • When am I at my best?
  • When negative thoughts arise how do I deal with them? Do my actions affect my peers positively, negatively or not at all?
  • What motivates me to make progress? How does this impact those around me?
  • What stresses me out? How do I manage my stress? How does my stress affect others?
  • How do I want others to see me? How do I think others see me?
  • Do I operate as a team player? Am I perceived as a team player by my peers?
  • Do I reward myself for a job well done?
  • Do I learn from a job that is not well done? Do I take accountability for this?
  • What does recognition look like to me?
  • Do I provide feedback to my peers without being asked?
  • Do I accept feedback, listen and reflect on it without exercising judgement towards the person who provided it?

Once you understand yourself, your strengths and your weaknesses, you can then leverage these and become a more effective behavioural leader. You don’t need to be assigned to a project or have a senior title to demonstrate behavioural leadership; it is an individual skill that can be used in all areas on a daily basis and is transferrable once mastered both inside and outside the workplace.

As you continue to practice a self-awareness approach and apply it to situations and events in your daily work routine, over time you will develop a non-judgemental approach in how you relate to others. Once self-awareness is exercised and the understanding of how your beliefs and values affect your behaviours, the next step is to identify what steps you can take that will have a direct and positive effect on how you conduct routine activities inside and outside the workplace.

The power of giving and receiving feedback can influence a person’s behaviour and how they conduct themselves. Providing feedback can be an effort in itself and it doesn’t always come to us naturally. Feedback allows people to modify their behaviour to help them attain their goals. Feedback can be delivered in different ways and it is important to exercise self-awareness prior to providing feedback to either your peers or your direct reports. Feedback should be timely and precise, and a clear distinction should be made between actions, results and people.

Every individual brings personal attitudes, skills, knowledge, habits and personalities to their role which can be either strengths or weaknesses depending on the task demands. It is important to consider individual characteristics that influence behaviour which influence investigations or issues or problems that arise in the workplace. When conducting root cause investigations in the pharmaceutical arena, human error is frequently under investigated and in many cases assigned as the root cause itself. Review and consideration of factors that affect an individual’s physical, mental and emotional capacity to adhere to standards of work practice should be encouraged. Self-awareness helps people to identify trends and biases in their own decision making. When you understand how you react to certain situations, you can implement strategies that lead to better decisions and lead by example for those around you.

There are many articles available on the internet that discuss self-awareness and how to apply it and the following article written by Scott Jeffrey is recommended for those that wish to read more on this – “How to Cultivate Self-Leadership”; https://scottjeffrey.com/self-leadership/

For further guidance on how to practice self-awareness skills you can visit the podcast at the following link: https://lifeskillsthatmatter.com/podcast/how-to-practice-self-awareness/

PharmaLex offers a wide range of training across all GxP services which include annual GxP training, Quality Culture, Data Integrity, Human Error Reduction and Quality Risk Management. The importance of understanding the relationship between human behaviours and their impact in the workplace is also factored into the training packages that can be developed and tailored to match the specific needs within your organisation. Why not connect with PharmaLex today +353 1 846 4742 or  contactirl@pharmalex.com and discuss your individual needs with a member of the PharmaLex team.

Related posts
Why collaboration and an Integrated Product Development program are key to successful drug development
Why collaboration and an Integrated Product Development program are key to successful drug development
14th June 2022
Key Takeaways from the PDA Europe Annex 1 Workshop
Key Takeaways from the PDA Europe Annex 1 Workshop
7th June 2022
NLS DAYS 2022
NLS DAYS 2022
September 28 - May 29th, 2022
Addressing Limitations of Sterility Testing
Addressing Limitations of Sterility Testing
9th May 2022
Are virtual audits sustainable post-pandemic?
Are virtual audits sustainable post-pandemic?
6th May 2022
Orphan Drug Designation: Securing the Significant Benefits
Orphan Drug Designation: Securing the Significant Benefits
28th March 2022
Search
Upcoming Webinars

June 28th, 2022

eCTD in Australia: key steps to start a successful submission

08:30 am CET / 4:30 pm AEST

June 28th, 2022

An Introduction to Bayesian adaptive methods in clinical trials

04:00 PM CET

June 30th, 2022

Transforming the drug development process with an integrated strategy

03:00 PM CET

Categories
  • All News
  • Webinars
  • Events
Archive
Biopharma Excellence Website Image

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

Visit Website
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
PharmaLexGLOBALPharmaLex@PharmaLexGLOBAL·
24 Jun

Milena Shuytsova-Mircheva and Lisa Pascoe latest blog here https://www.pharmalex.com/sponsors-gear-up-for-a-smoother-process-with-ctis-but-must-first-overcome-key-hurdles/ discusses the benefit of the Clinical Trial Information System (CTIS).

💡 Interested in CTIS? Take the Phlexglobal survey to evaluate your preparation https://www.phlexglobal.com/ctis-survey

COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • Our project team were very impressed with the quality of the research and the reports that you sent through. We didn’t need any convincing that your recommendations should be followed. It showed PharmaLex in a very positive light, and the Project Team are keen to work with you again.

    Leading European Specialist Pharma Company
    Head of Medical Writing and Publications
PharmaLex
©2022 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit LogoSGS Logo

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team

    Please DO NOT send us event/conference information.
    We will not respond and these will be deleted immediately.






    Select your state:

    .
    If you do not wish to receive any communication from us, you may unsubscribe at any time.

    #AskTheExpert #TogetherBEYONDCOVID19





      Select your state:

      .
      You can unsubscribe at any time at data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      #TogetherBEYONDCOVID19

      We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for